ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $901 | -5.8% | 34,663 | +3.7% | 0.00% | -50.0% |
Q1 2024 | $956 | -7.9% | 33,413 | -1.5% | 0.00% | 0.0% |
Q4 2023 | $1,038 | +12.8% | 33,928 | -0.9% | 0.00% | 0.0% |
Q3 2023 | $920 | -25.0% | 34,242 | -0.4% | 0.00% | 0.0% |
Q2 2023 | $1,226 | +41.4% | 34,390 | +0.6% | 0.00% | 0.0% |
Q1 2023 | $867 | +241.3% | 34,172 | +444.9% | 0.00% | +100.0% |
Q4 2022 | $254 | -99.9% | 6,271 | -3.7% | 0.00% | 0.0% |
Q3 2022 | $215,000 | -9.7% | 6,513 | -3.7% | 0.00% | 0.0% |
Q2 2022 | $238,000 | -8.1% | 6,764 | +19.8% | 0.00% | 0.0% |
Q1 2022 | $259,000 | -37.0% | 5,648 | -9.0% | 0.00% | 0.0% |
Q4 2021 | $411,000 | +2.2% | 6,209 | -3.7% | 0.00% | 0.0% |
Q3 2021 | $402,000 | -55.6% | 6,449 | -41.0% | 0.00% | -50.0% |
Q2 2021 | $905,000 | +11.9% | 10,934 | -10.4% | 0.00% | 0.0% |
Q1 2021 | $809,000 | -13.8% | 12,203 | -0.3% | 0.00% | -33.3% |
Q4 2020 | $939,000 | +82.0% | 12,238 | +2.0% | 0.00% | +50.0% |
Q3 2020 | $516,000 | 0.0% | 12,002 | +0.3% | 0.00% | 0.0% |
Q2 2020 | $516,000 | +54.0% | 11,968 | +2.6% | 0.00% | 0.0% |
Q1 2020 | $335,000 | -61.5% | 11,665 | -15.1% | 0.00% | -33.3% |
Q4 2019 | $871,000 | +190.3% | 13,740 | +29.0% | 0.00% | +200.0% |
Q3 2019 | $300,000 | +17.6% | 10,650 | +10.4% | 0.00% | 0.0% |
Q2 2019 | $255,000 | +29.4% | 9,650 | -10.5% | 0.00% | 0.0% |
Q1 2019 | $197,000 | – | 10,785 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |